WHO ICTRP trial
To explore the clinical efficacy and safety of MTX in the treatment of moderate…
ChiCTR2200063752 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200063752 |
|---|---|
| Public title | To explore the clinical efficacy and safety of MTX in the treatment of moderate and severe psoriasis |
| Scientific title | To explore the clinical efficacy and safety of MTX in the treatment of moderate and severe psoriasis |
| Primary sponsor | Shanghai Skin Disease Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | psoriasis |
| Interventions | Group 1 :7.5 mg/week;Group 2:10 mg/week;Group 3:15 mg/week |
| Registration date | Sep 15, 2022 |
| Target size | Group 1 :136;Group 2:136;Group 3:136 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: